Kalan Patel

Internal Medicine Resident at East Tennessee State University with a focused commitment to health-equity research and evidence-based clinical practice. Actively engaged in quality-improvement initiatives and interdisciplinary collaboration to address disparities in care delivery. Participates in complex transplant cases at Vanderbilt University Medical Center, integrating clinical insight with academic inquiry. Dedicated to advancing patient-centered outcomes through innovative research and collaborative scholarship.

• Breast Cancer Awareness Lecture, WHO Breast Cancer Awareness Week, 2018, Delivered educational talk to secondary school students on early detection and self‑examination, promoting community health literacy.
• Community Health Outreach, Engaged in public‑health initiatives focusing on cancer prevention, vaccination campaigns and health‑screening camps.

• American Society of Hematology (ASH), Student/Resident Member
• American Society of Clinical Oncology (ASCO), Resident Member
• American College of Physicians (ACP)

• Bone Marrow Transplant Clinic Observership, Vanderbilt University Medical Center (BMT Clinic), 2021, Observed complex autologous and allogeneic transplant cases, gaining exposure to conditioning regimens, GVHD prophylaxis and post‑transplant care. Participated in multidisciplinary rounds, deepening understanding of hematologic malignancy management.
• Internal Medicine Residency Rotations, 2024–present, Managed diverse inpatient oncology cases including neutropenic fever, AML induction and complications of chemotherapy. Led daily patient‑centered rounds, collaborating with palliative care, infectious disease and hematology/oncology teams.

1.  Cutaneous Metastasis of Gastric Adenocarcinoma: A Report of a Rare Case and a Literature Review – Cureus(2025). DOI 10.7759/cureus.92805.

–  First‑author case report describing an atypical cutaneous presentation of gastric adenocarcinoma, emphasising the importance of early biopsy for prompt oncologic intervention.

2.  Chronic Myeloid Leukemia in a Young Adult – Cureus (2025). DOI 10.7759/cureus.81220.

–  Detailed case report of an aggressive chronic myeloid leukemia presenting in a young patient; discussed diagnostic challenges and therapeutic strategies.

3.  Global Trigger Tool: Proficient Adverse Drug Reaction Autodetection Method in Critical Care Patient Units – Indian Journal of Critical Care Medicine (2020). DOI 10.5005/jp‑journals‑10071‑23367.

–  Contributed to developing a trigger‑based algorithm for early detection of adverse drug reactions in intensive care units.

4.  Bone Marrow Biopsy Showing Concurrent Multiple Myeloma and Prostate Carcinoma: Morphologic and Immunohistochemical Features – American Society of Hematology (ASH) Image Bank (2025).

–  Published a visual case highlighting dual malignancy within bone marrow; provided morphologic and immunohistochemical description. (The ASH image bank does not assign a DOI; citation available via the ASH Image Bank).

American Society of Hematology (ASH) Annual Meeting

1. Therapy‑related malignancies in myeloma: SEER comparison of IMiD vs anti‑CD38 eras.
2. Total metabolic tumor volume as a prognostic biomarker in high‑burden follicular lymphoma: Systematic review and meta‑analysis.
3. Anti‑BCMA CAR T‑cell therapy in relapsed/refractory multiple myeloma with extramedullary disease: Comparative outcomes and evolving strategies.
4. Causal role of gut microbiota in immune thrombocytopenia: Mendelian randomisation systematic review.
5. Impact of allogeneic transplant vs hypomethylating agents in high‑risk myelodysplastic syndromes: PRISMA‑guided systematic review.
6. Comparative 3‑ and 5‑year outcomes among first‑line imatinib, dasatinib and nilotinib in chronic myeloid leukemia: Real‑world analysis.
7. Incidence and outcomes of Clostridioides difficile infection in BCMA and CD19 CAR‑T‑cell therapy.

American College of Physicians (ACP) & Society of Hospital Medicine (SHM)

1. Hospitalization outcomes and palliative‑care access in metastatic breast cancer: Sociodemographic analysis of the National Inpatient Sample.
2. Pernicious anemia‑related vitamin B12 deficiency presenting as pseudo‑thrombotic microangiopathy.
3. Impact of sociodemographic factors on mortality among colorectal cancer hospitalizations: Insights from a national representative sample.
4. Recognizing the silent burden: Quality‑improvement project on iron deficiency without anemia.

American Society of Clinical Oncology (ASCO) GI & GU Symposia

1. Clinical and economic implications of venous thromboembolism in pancreatic cancer: Analysis using the National Inpatient Sample.
2. Impact of missing bleomycin doses in BEP ×3 regimen for non‑seminomatous germ cell tumors: Systematic review and meta‑analysis.

National Comprehensive Cancer Network (NCCN) Conference
1. Radiomics and machine‑learning models for predicting early recurrence after pancreatic cancer resection: Systematic review.
2. Genetically determined circulating metabolites and pancreatic cancer risk: Mendelian randomisation systematic review.

Southern Regional Conference

1. Impact of Sociodemographic Factors on Mortality Among Colorectal Cancer Hospitalizations: Presented at the Southern Regional Conference; evaluated how socioeconomic and racial factors influence mortality outcomes in colorectal cancer hospitalizations.
2. Recognizing the Silent Burden: A Quality Improvement Project on Iron Deficiency Without Anemia: Led a quality‑improvement project from conception to presentation; designed the study protocol, collected and analysed data, implemented interventions and presented findings at the Southern Regional Conference.